Among them is the Dean of the Institute, a team of expert teachers who applied for a patent entitled “Comprehensive Anthraquine Extraction for Medical Treatments in a Pivotal Method.”

A team of professors from the Institute of Genetic Engineering and Biotechnology for Postgraduate Studies / University of Baghdad obtained a patent from the Central Organization for Standardization and Quality Control of the Iraqi Ministry of Planning, entitled: “Extraction of anthraquinones with wide medical uses in a modified method.”
The team consisted of the teaching staff in the Biotechnology Branch, Assistant Professor Dr. Abdul Mohsen Muslim Shami, Professor Dr. Shorouk Muhammad Kazem, and Assistant Professor Dr. Saif Daoud Al-Ahmar/Dean of the Institute.
The patent aimed to study the use of different organic solvents to extract anthraquinones from the jasmine plant, which is characterized by its high content of anthraquinones compared to other plants.
The patent indicated that anthraquinones are characterized by their many medical benefits, such as an antioxidant for most cancer cells and bacteria, and for their usefulness in the pharmaceutical industry.
The patent identified the following compounds: – Emodin, 1,4-dihydroxyanthraquinone, 1-methoxyanthroquinone, 2-ethylthroquinone, 9,10-Anthracenedione, 1,5-Dihydroxyanthrachinon, 1,4-Dimethoxybenzene, 1,4-cyclohexanedione and 2,3-Dimethylquinone.
​